{"id":821119,"date":"2025-03-04T07:08:02","date_gmt":"2025-03-04T12:08:02","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences\/"},"modified":"2025-03-04T07:08:02","modified_gmt":"2025-03-04T12:08:02","slug":"aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences\/","title":{"rendered":"Aclaris Therapeutics to Participate in Two March Healthcare Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">WAYNE, Pa., March  04, 2025  (GLOBE NEWSWIRE) &#8212; Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company will participate in two upcoming healthcare conferences in March.<\/p>\n<ul type=\"disc\">\n<li>On Tuesday March 11, 2025, at 3:00 PM EDT, Aclaris\u2019 Chief Executive Officer Dr. Neal Walker and other members of Aclaris\u2019 senior leadership team will participate in a fireside chat during the Leerink Partners Global Healthcare Conference in Miami, Florida.\n<\/li>\n<li>On Thursday March 27, 2025, at 9:00 AM EDT, Dr. Walker and other members of Aclaris\u2019 senior leadership team will participate in a virtual fireside chat during the H.C. Wainwright 3rd Annual Autoimmune &amp; Inflammatory Disease Virtual Conference<\/li>\n<\/ul>\n<p>A live and archived webcast of both events will be accessible on the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=llyBovf8wvCRD7--PeEsYRkWfHYpzNILAaTwwLa8BehaGjiw0XBfMVJ3GQUHurxSHaibpwMszv9rVSbDwGu5cmDL304AYtTehh-9Pdyxsbs=\" rel=\"nofollow\" target=\"_blank\">Events page<\/a> of <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=F5qP6oz6XltCvG6hmJrDBUgbivrmm4_5QquPwbohJrA8pUhAEHwL0VrWkGptbCcbjdJKrLbegPFFmXnyT8s_ozEtNVK3iGkmJaj7NX28fm0=\" rel=\"nofollow\" target=\"_blank\">https:\/\/www.aclaristx.com\/<\/a>. The webcasts will be available on the Aclaris website for at least 30 days.<\/p>\n<p>\n        <strong>About Aclaris Therapeutics, Inc.<\/strong>\n      <\/p>\n<p>Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel product candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of product candidates powered by a robust R&amp;D engine. For additional information, please visit www.aclaristx.com and follow Aclaris on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FocORWFd2qtT54zo1FTzfl2q-birSklChOZrPtYBsnJeI8J4yQdBJzoXWMfMmMWH\" rel=\"nofollow\" target=\"_blank\">X<\/a> (formerly Twitter) at @AclarisTx and on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=plajMUhd9ZH1vMEBBO8inmKJUoJpBf2fc8tJUZjYEE78xowNVczP85UGSVe5XtyrzdyM0u741-IGhD__keM0gdPodUCgtDjfJSOuCkXCUsRJru7R0_bLPbRuzIVcYqwG\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>\n        <strong>Aclaris Therapeutics Contact:<\/strong>\n      <\/p>\n<p>\n        <strong>Will Roberts<\/strong><br \/>\n        <br \/>Senior Vice President<br \/>Corporate Communications and Investor Relations<br \/>(484) 329-2125<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6ofEOREhyK8KDPoVP_W0y_olsltcWkjzeIuS1k5ZQeJzMtfdzP_2eia91ykswyfQAgf99eOXAmbSsoHiiSkftn3M7wkkcWjMyNTvsNNY5Y0=\" rel=\"nofollow\" target=\"_blank\">wroberts@aclaristx.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Nzk0NSM2Nzg3NzczIzIwMjAxODM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YWIwZDQ2N2EtZDhiZC00NDQ1LWIyODAtOWI4NjUxODBlN2I0LTEwMzE3NTU=\/tiny\/Aclaris-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WAYNE, Pa., March 04, 2025 (GLOBE NEWSWIRE) &#8212; Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company will participate in two upcoming healthcare conferences in March. On Tuesday March 11, 2025, at 3:00 PM EDT, Aclaris\u2019 Chief Executive Officer Dr. Neal Walker and other members of Aclaris\u2019 senior leadership team will participate in a fireside chat during the Leerink Partners Global Healthcare Conference in Miami, Florida. On Thursday March 27, 2025, at 9:00 AM EDT, Dr. Walker and other members of Aclaris\u2019 senior leadership team will participate in a virtual fireside chat during the H.C. Wainwright 3rd Annual Autoimmune &amp; Inflammatory Disease Virtual Conference A live &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Aclaris Therapeutics to Participate in Two March Healthcare Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-821119","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aclaris Therapeutics to Participate in Two March Healthcare Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aclaris Therapeutics to Participate in Two March Healthcare Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WAYNE, Pa., March 04, 2025 (GLOBE NEWSWIRE) &#8212; Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company will participate in two upcoming healthcare conferences in March. On Tuesday March 11, 2025, at 3:00 PM EDT, Aclaris\u2019 Chief Executive Officer Dr. Neal Walker and other members of Aclaris\u2019 senior leadership team will participate in a fireside chat during the Leerink Partners Global Healthcare Conference in Miami, Florida. On Thursday March 27, 2025, at 9:00 AM EDT, Dr. Walker and other members of Aclaris\u2019 senior leadership team will participate in a virtual fireside chat during the H.C. Wainwright 3rd Annual Autoimmune &amp; Inflammatory Disease Virtual Conference A live &hellip; Continue reading &quot;Aclaris Therapeutics to Participate in Two March Healthcare Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-04T12:08:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Nzk0NSM2Nzg3NzczIzIwMjAxODM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Aclaris Therapeutics to Participate in Two March Healthcare Conferences\",\"datePublished\":\"2025-03-04T12:08:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences\\\/\"},\"wordCount\":239,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4Nzk0NSM2Nzg3NzczIzIwMjAxODM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences\\\/\",\"name\":\"Aclaris Therapeutics to Participate in Two March Healthcare Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4Nzk0NSM2Nzg3NzczIzIwMjAxODM=\",\"datePublished\":\"2025-03-04T12:08:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4Nzk0NSM2Nzg3NzczIzIwMjAxODM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4Nzk0NSM2Nzg3NzczIzIwMjAxODM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aclaris Therapeutics to Participate in Two March Healthcare Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aclaris Therapeutics to Participate in Two March Healthcare Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Aclaris Therapeutics to Participate in Two March Healthcare Conferences - Market Newsdesk","og_description":"WAYNE, Pa., March 04, 2025 (GLOBE NEWSWIRE) &#8212; Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company will participate in two upcoming healthcare conferences in March. On Tuesday March 11, 2025, at 3:00 PM EDT, Aclaris\u2019 Chief Executive Officer Dr. Neal Walker and other members of Aclaris\u2019 senior leadership team will participate in a fireside chat during the Leerink Partners Global Healthcare Conference in Miami, Florida. On Thursday March 27, 2025, at 9:00 AM EDT, Dr. Walker and other members of Aclaris\u2019 senior leadership team will participate in a virtual fireside chat during the H.C. Wainwright 3rd Annual Autoimmune &amp; Inflammatory Disease Virtual Conference A live &hellip; Continue reading \"Aclaris Therapeutics to Participate in Two March Healthcare Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-04T12:08:02+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Nzk0NSM2Nzg3NzczIzIwMjAxODM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Aclaris Therapeutics to Participate in Two March Healthcare Conferences","datePublished":"2025-03-04T12:08:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences\/"},"wordCount":239,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Nzk0NSM2Nzg3NzczIzIwMjAxODM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences\/","name":"Aclaris Therapeutics to Participate in Two March Healthcare Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Nzk0NSM2Nzg3NzczIzIwMjAxODM=","datePublished":"2025-03-04T12:08:02+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Nzk0NSM2Nzg3NzczIzIwMjAxODM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Nzk0NSM2Nzg3NzczIzIwMjAxODM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aclaris-therapeutics-to-participate-in-two-march-healthcare-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Aclaris Therapeutics to Participate in Two March Healthcare Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/821119","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=821119"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/821119\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=821119"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=821119"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=821119"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}